Aplastic anemia

36,141views

Aplastic anemia

POM

POM

Gluconeogenesis
Glycogen metabolism
Amino acid metabolism
Fatty acid synthesis
Fatty acid oxidation
Ketone body metabolism
Cholesterol metabolism
Carbohydrates and sugars
Fats and lipids
Proteins
Cellular structure and function
Cell membrane
Selective permeability of the cell membrane
Extracellular matrix
Cell-cell junctions
Endocytosis and exocytosis
Osmosis
Resting membrane potential
Nernst equation
Cell signaling pathways
Cytoskeleton and intracellular motility
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Amino acids and protein folding
Protein structure and synthesis
Nucleotide metabolism
DNA replication
Lac operon
DNA damage and repair
Cell cycle
Mitosis and meiosis
DNA mutations
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
ELISA (Enzyme-linked immunosorbent assay)
Karyotyping
DNA cloning
Fluorescence in situ hybridization
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Gene regulation
Epigenetics
Evolution and natural selection
Bacterial structure and functions
Free radicals and cellular injury
Necrosis and apoptosis
Ischemia
Hypoxia
Inflammation
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Blood histology
Blood components
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Fanconi anemia
Megaloblastic anemia
Diamond-Blackfan anemia
Chronic leukemia
Acute leukemia
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Thymus histology
Spleen histology
Lymph node histology
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity

Transcript

Watch video only

Aplastic anemia is a pancytopenia, meaning all blood cell lines are decreased - so the term aplastic anemia, which just refers to low red blood cell count, is actually a misnomer.

So with aplastic anemia, there’s actually anemia, as well as leukocytopenia, or low white blood cells, as well as thrombocytopenia, or low platelet levels.

This condition takes many forms, ranging from mild to severe depending on the cause.

Now, blood cells are produced in the bones of the body, mainly in the bones of the pelvis, ribs and sternum, through a process called hematopoiesis.

This process starts in the bone marrow, the innermost portion of bone, where the hematopoietic stem cells reside.

These serve as progenitor cells for all the different cell types found in the blood.

First, hematopoietic stem cells, also called hemocytoblasts, can become lymphoid progenitors or myeloid progenitors.

The lymphoid progenitors can develop into lymphoblasts, which can then differentiate into some white blood cells like T-lymphocytes, B-lymphocytes, or natural killer cells.

The myeloid progenitors can differentiate into erythrocytes, or red blood cells, megakaryocytes, which eventually give rise to platelets, or myeloblasts, which can then become other white blood cells like monocytes, neutrophils, basophils, and eosinophils.

The most common cause of aplastic anemia is autoimmune destruction of hematopoietic stem cells.

The details of this mechanism are not fully understood, but research shows that there are alterations in the immunologic appearance of hematopoietic stem cells because of genetic disorders, or after exposure to environmental agents, like radiation or toxins.

This means that the hematopoietic stem cells start expressing non-self antigens and the immune system subsequently targets them for destruction.

As the immune system destroys hematopoietic stem cells a whole host of complications arise.

Due to the low red blood cell count tissues cannot properly oxygenate so the heart pumps harder to circulate the red blood cells leading to chest pain and shortness of breath.

Low platelet counts lead to an increased risk of bleeding from the most minor injuries and in mucosal areas. Low white blood cells counts lead to the body’s inability to fight off common infections that can lead to sepsis.

Now, there are many causes of aplastic anemia, but the disease is most often idiopathic, or without an identifiable cause.

Definable causes of aplastic anemia include radiation and toxins like insecticides or industrial agents that contain benzene.

Drugs that may cause aplastic anemia include chemotherapeutic agents, anti-seizure medications, antiinflammatory medications like indomethacin, antithyroid medications like propylthiouracil and methimazole, and antibiotics like chloramphenicol and sulfonamides.

Key Takeaways

Aplastic anemia is a rare blood disorder caused by bone marrow failure to produce new blood cells. Even though it's referred to as aplastic anemia, it typically presents with pancytopenia, meaning that all three major blood cell lines - the red blood cells, white blood cells, and platelets are affected.

People with aplastic anemia may experience fatigue, shortness of breath, ecchymoses and mucosal bleeding, and frequent infections pallor Aplastic anemia can be caused by a variety of factors, including exposure to radiation or chemotherapy, viral infections, and autoimmune disorders.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Current concepts in the pathophysiology and treatment of aplastic anemia" Hematology (2013)
  4. "Aplastic anaemia" Hematology (2013)
  5. "Aplastic Anemia" New England Journal of Medicine (2018)
  6. "Harrison's Principles of Internal Medicine" McGraw-Hill (2004)
  7. "The complex pathophysiology of acquired aplastic anaemia" Clinical & Experimental Immunology (2015)